SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-032120
Filing Date
2024-04-11
Accepted
2024-04-11 13:33:04
Documents
3
Period of Report
2024-04-11

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0203676-6k_akanda.htm 6-K 12669
2 PRESS RELEASE ISSUED BY AKANDA CORP. TO ANNOUNCE THE CLOSING OF THE SALE OF RPK ea020367601ex99-1_akanda.htm EX-99.1 12507
3 PRESS RELEASE ISSUED BY AKANDA CORP. TO ANNOUNCE PLAN TO INTEGRATE TECHNOLOGY SO ea020367601ex99-2_akanda.htm EX-99.2 14351
  Complete submission text file 0001213900-24-032120.txt   40601
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41324 | Film No.: 24837917
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)